Astrazeneca to begin Phase 1/2 clinical trials of coronavirus vaccine in Japan
Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate. Trials of the vaccine, known as AZD1222, will be conducted at multiple…
